International Stem Cell Corp (ISCO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
October 2018
38
About the Report
About the Report
Summary
International Stem Cell Corp (ISCC) is a clinical stage biotechnology company that develops stem cell technology solutions. The company develops parthenogenesis, a stem cell technology that improves the field of regenerative medicine. It provides stem cells such as embryonic stem cells, adult stem cells, induced pluripotent stem cells, and parthenogenetic stem cells. ISCC uses human parthenogenetic stem cells (hpSC) to treat severe diseases of the central nervous system, joints and liver. The company has also developed a new class of pluripotent human stem cells derived from unfertilized eggs. It also conducts clinical trials for the treatment of moderate to severe Parkinson's disease. ISCC is headquartered in Carlsbad, California, the US.
International Stem Cell Corp (ISCO)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
International Stem Cell Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
International Stem Cell Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
International Stem Cell Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
International Stem Cell Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
International Stem Cell Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
International Stem Cell Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
International Stem Cell Corp, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
International Stem Cell Enters into Research Agreement with Florey Institute of Neuroscience and Mental Health 11
International Stem Cell Enters into Research Agreement with Rohto Pharma 12
Equity Offering 13
International Stem Cell Raises USD0.5 Million in Private Placement of Shares 13
International Stem Cell to Raise USD2.5 Million in Private Placement of Preferred Stock 14
International Stem Cell Files Registration Statement for Private Placement of Shares and Warrants 16
International Stem Cell to Raise USD2.5 Million in Private Placement of Preferred Shares and Warrants 17
International Stem Cell Completes Private Placement Of Shares For USD 0.3 Million 19
International Stem Cell Completes Public Offering Of Units For USD 3 Million 20
International Stem Cell Completes Private Placement Of Shares For USD 1 Million 21
International Stem Cell Completes Private Placement Of Series G Convertible Preference Stock For USD 5 Million 22
International Stem Cell Corp-Key Competitors 23
International Stem Cell Corp-Key Employees 24
International Stem Cell Corp-Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Joint Venture 25
Recent Developments 26
Strategy And Business Planning 26
Jul 10, 2018: International Stem Cell Expands Manufacturing Capabilities for Biomedical Products 26
Sep 26, 2017: International Stem Cell to Expand its Revenue Generating Biomedical Businesses to Support Ongoing and Future Clinical Trials 27
Financial Announcements 28
Aug 15, 2018: International Stem Cell announces record sales and operating results for the three and six-months ended June 30, 2018 28
May 22, 2018: International Stem Cell Announces Operating Results for the Quarter Ended March 31, 2018 29
Apr 10, 2018: International Stem Cell Announces 2017 Fourth Quarter and Year-End Results 30
Nov 17, 2017: International Stem Cell Announces Operating Results for the Three and Nine-Months ended September 30, 2017 31
Aug 14, 2017: International Stem Cell Announces Operating Results for the Three and Six-Months ended June 30, 2017 32
May 17, 2017: International Stem Cell Announces Operating Results for the Quarter ended March 31, 2017 33
Apr 05, 2017: International Stem Cell Announces 2016 Fourth Quarter and Year-End Results 34
Product News 35
Oct 09, 2017: International Stem Cell Developed 3D Bioprinting Technology Targeted to Treat Liver Diseases 35
May 30, 2018: International Stem Cell Published Technology for Cartilage Generation in Journal of Tissue Engineering and Regenerative Medicine Technology 36
Other Significant Developments 37
Aug 06, 2018: International Stem Cell developed 3D liver structures 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38
List of Figure
List of Figures
International Stem Cell Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
International Stem Cell Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
International Stem Cell Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
International Stem Cell Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
International Stem Cell Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
International Stem Cell Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
International Stem Cell Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
International Stem Cell Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
List of Table
List of Tables
International Stem Cell Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
International Stem Cell Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
International Stem Cell Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
International Stem Cell Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
International Stem Cell Corp, Deals By Therapy Area, 2012 to YTD 2018 9
International Stem Cell Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
International Stem Cell Enters into Research Agreement with Florey Institute of Neuroscience and Mental Health 11
International Stem Cell Enters into Research Agreement with Rohto Pharma 12
International Stem Cell Raises USD0.5 Million in Private Placement of Shares 13
International Stem Cell to Raise USD2.5 Million in Private Placement of Preferred Stock 14
International Stem Cell Files Registration Statement for Private Placement of Shares and Warrants 16
International Stem Cell to Raise USD2.5 Million in Private Placement of Preferred Shares and Warrants 17
International Stem Cell Completes Private Placement Of Shares For USD 0.3 Million 19
International Stem Cell Completes Public Offering Of Units For USD 3 Million 20
International Stem Cell Completes Private Placement Of Shares For USD 1 Million 21
International Stem Cell Completes Private Placement Of Series G Convertible Preference Stock For USD 5 Million 22
International Stem Cell Corp, Key Competitors 23
International Stem Cell Corp, Key Employees 24
International Stem Cell Corp, Other Locations 25
International Stem Cell Corp, Subsidiaries 25
International Stem Cell Corp, Joint Venture 25
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.